SHL Telemedicine LtdSHL Telemedicine LtdSHL Telemedicine Ltd

SHL Telemedicine Ltd

No trades
See on Supercharts
Next report date
Report period
H1 2024
EPS estimate
−0.17USD
Revenue estimate
‪29.00 M‬USD
Market capitalization
‪84.93 M‬USD
−0.43USD
‪−7.04 M‬USD
‪56.93 M‬USD
Beta (1Y)
0.40

About SHL TELEMEDICINE N

CEO
Erez Nachtomy
Headquarters
Tel Aviv
Employees (FY)
583
Founded
1987
FIGI
BBG01G2G1BK7
SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions, which focuses on cardiovascular and related diseases. Its products and solutions include congestive heart failure, chronic obstructive pulmonary disease and cardiac monitoring services. It operates through the following geographical segments: Israel, Europe principally Germany, and Rest of the World. The company was founded by Yoram Alroy and Elon Shalev in 1987 and is headquartered in Tel Aviv, Israel.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.